Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.
Individual Clinical
Pharmacokinetics & Abuse Liability; Safety
Adverse Effects
Cobb (2021)
Changes in Biomarkers of Cigarette Smoke Exposure after 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: a Randomized Controlled Confinement Study in adult Smokers.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Cohen (2021)
Combinations of electronic nicotine delivery system device and liquid characteristics among U.S. adults.
Individual Clinical
User Topography
Cohen (2022)
assessing the association Between Electronic Cigarette Use among Cannabis-Naive adolescents and Future Cannabis Use-Overlapping Substances.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Compton (2022)
how Irritating! Electronic Cigarettes Not “95% Safer” Than Combustible Cigarettes: Recent Mechanistic Insights Into Endothelial Dysfunction.
Individual Clinical
Safety
Adverse Effects
Conklin (2022)
Time-varying association between cigarette and ENDS use on incident hypertension among US adults: a prospective longitudinal study.
Individual Clinical
Safety
Adverse Effects
Cook (2023)
Characterizing ENDS use in young adults with ecological momentary assessment: Results from a pilot study.
Individual Clinical
Consumer Use
Youth Use & Appeal
Cooper (2019)
Gene Expression alterations in the Bronchial Epithelium of e-Cigarette Users.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Corbett (2019)
Vascular effects of a single bout of electronic cigarette use.
Individual Clinical
Safety
Adverse Effects
Cossio (2020)